INPP5D and plasma cell myeloma: The observation that both agonists and antagonists of SHIP1 are cytotoxic to multiple myeloma cells highlights the delicate balance of PI(3,4,5)P3 and PI(3,4)P2 a cancer cell must maintain in order to develop and perpetuate the malignant state.